Consistent with the study by Mei et al., which showed that heterozygous knockout of M1R in OPCs conferred comparable protection to the homozygous knockout mice in the MOG-EAE model of MS, our data would suggest that full M1R occupancy is not needed to achieve full efficacy. This evidence concerns the gene CHRM1 and myeloid sarcoma.